Significant ALK IHC staining of E5193 was established on 100 cells only (25% of tumor cells in the sample) and patient E5680 was an active smoker with large cell neuroendocrine carcinoma, not prone to present ALK rearrangement. This evidence concerns the gene ALK and large cell neuroendocrine carcinoma.